Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

Tag: America

Browse our exclusive articles!

Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation

GlaxoSmithKline plc announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Tafinlar® (dabrafenib) for treatment of patients with...

Some ‘healthy’ vegetable oils may actually increase risk of heart disease

Some vegetable oils that claim to be healthy may actually increase the risk of heart disease, and Health Canada should reconsider cholesterol-lowering claims on...

Discovery may lead to new treatments for allergic diseases

A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that has broad implications for...

Breakthrough by researchers could lead to new treatment for heart attack

The stop and start of blood flow to the heart during and after a heart attack causes severe damage to heart cells, reducing their...

Stem cell breakthrough could set up future transplant therapies

A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient...

Popular

Building the Right Team and Resource Model to Support Quality System and Validation Activities

Since life science quality and validation projects can vary...

Merck and Blackstone Enter R&D Funding Agreement for sac-TMT

Merck, recognized as MSD outside the U.S. and Canada,...

FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

Johnson & Johnson said the U.S. Food and Drug...

FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

UCB, a leading global biopharmaceutical company, has announced that...

Subscribe

spot_imgspot_img